GlassScriptPhysician profile
Constantine Melitas
NPI 1154731321
$2,933.88
in general payments reported to CMS, 2019-2025
6 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $249 · 2021: $187 · 2022: $439 · 2023: $751 · 2024: $720 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759 · Travel and Lodging: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,759.23 |
| Travel and Lodging | $160.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,217.73 | 2021-2025 | Overstitch Endoscopic Suturing System, Exalt Model D, Orise |
| Olympus America INC. | $308.54 | 2020-2024 | Single Use Electrosurgical Knife Kd-655 |
| Gilead Sciences, INC. | $243.84 | 2019-2020 | |
| Micro-Tech Endoscopy USA, INC. | $91.80 | 2021 | |
| Abbvie INC. | $54.13 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Melitas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.